Post-earnings recap
Reported
Thu, Nov 9, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
38%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Immunome Inc's earnings report showed a loss per share of $0.36, with no revenue figures disclosed. The stock reacted negatively, declining by 2.73%. The lack of guidance and specific revenue data may have contributed to investor uncertainty.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.36 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Management acknowledged the challenges faced in the quarter. They emphasized their commitment to advancing their research initiatives.
Management did not provide specific revenue figures or future guidance.
The focus remains on ongoing research and development efforts.